EUVIMEDEUVIMED entdecken
Open Access

Prevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X/47, XXX ): Results from the InsighTS Registry

Natalia Klamut iD, Samantha Bothwell, Alexandra E Carl iD, Vaneeta Bamba, Jennifer R Law, Wendy J Brickman, Karen O Klein, Roopa Kanakatti Shankar iD, Catherina T Pinnaro iD, Patricia Y Fechner, Siddharth K Prakash, Iris Gutmark-Little iD und 5 weitere

American Journal of Medical Genetics Part A · 2024-12 · 194 (12)

DOI: 10.1002/ajmg.a.63819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 17.07.2024. Verfasst von Natalia Klamut und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Colorado School of Medicine, Colorado, Aurora, USA. Hauptthemen laut MEDLINE: Turner Syndrome, Chromosomes, Human, X, Trisomy, Mosaicism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Science Foundation, Turner Syndrome Global Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Turner syndrome (TS) is defined by partial or complete absence of a sex chromosome. Little is known about the phenotype of individuals with TS mosaic with trisomy X (45,X/47,XXX or 45,X/46,XX/47,XXX) (~3% of TS). We compared the diagnostic, perinatal, medical, and neurodevelopmental comorbidities of mosaic 45,X/47,XXX ( n = 35, 9.4%) with nonmosaic 45,X ( n = 142) and mosaic 45,X/46,XX ( n = 66). Females with 45,X/47,XXX had fewer neonatal concerns and lower prevalence of several TS‐related diagnoses compared with 45,X; however the prevalence of neurodevelopmental and psychiatric diagnoses were not different. Compared to females with 45,X/46,XX, the 45,X/47,XXX group was significantly more likely to have structural renal anomalies (18% vs. 3%; p = 0.03). They were twice as likely to have congenital heart disease (32% vs. 15%, p = 0.08) and less likely to experience spontaneous menarche (46% vs. 75% of those over age 10, p = 0.06), although not statistically significant. Congenital anomalies, hypertension, and hearing loss were primarily attributable to a higher proportion of 45,X cells, while preserved ovarian function was most associated with a higher proportion of 46,XX cells. In this large TS cohort, 45,X/47,XXX was more common than previously reported, individuals were phenotypically less affected than those with 45,X, but did have trends for several more TS‐related diagnoses than individuals with 45,X/46,XX.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Turner SyndromeChromosomes, Human, XTrisomyMosaicismRegistriesHumansFemalePrevalenceAdultAdolescentSex Chromosome AberrationsChildPhenotypeChild, PreschoolSex Chromosome Disorders of Sex DevelopmentYoung AdultInfantInfant, NewbornHeart Defects, Congenital

Stichwörter der Autor:innen

Trisomy X syndromeTurner syndromemosaicismphenotypesex chromosome aneuploidy

Autor:innen und Institutionen

  • Department of Pediatrics, University of Colorado School of Medicine, Colorado, Aurora, USA.
  • eXtraOrdinary Kids Turner Syndrome Clinic, Children's Hospital of Colorado, Colorado, Aurora, USA.
  • Division of Endocrinology, Children's Hospital of Philadelphia Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Pediatric Endocrinology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Pediatrics, Northwestern University Feinberg School of Medicine, Turner Syndrome Program, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Pediatrics, University of California and Rady Children's Hospital, San Diego, California, USA.

ORCID-Profile: Natalia Klamut, Alexandra E Carl, Roopa Kanakatti Shankar, Catherina T Pinnaro, Iris Gutmark-Little, Susan Howell

Förderung

  • NIDDK NIH HHS
  • National Science Foundation
  • Turner Syndrome Global Alliance
  • Boettcher Foundation
  • NIH/NCATS
  • NICHD NIH HHS
  • Turner Syndrome Colorado
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Klamut, N., Bothwell, S., Carl, A. E., Bamba, V., Law, J. R., Brickman, W. J., Klein, K. O., Kanakatti Shankar, R., Pinnaro, C. T., Fechner, P. Y., Prakash, S. K., Gutmark-Little, I., Howell, S., Tartaglia, N., Good, M., Ranallo, K. C., & Davis, S. M. (2024). Prevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X/47, XXX ): Results from the InsighTS Registry. American Journal of Medical Genetics Part A, 194(12). https://doi.org/10.1002/ajmg.a.63819

Vancouver

Klamut N, Bothwell S, Carl AE, Bamba V, Law JR, Brickman WJ, et al. Prevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X/47, XXX ): Results from the InsighTS Registry. American Journal of Medical Genetics Part A. 2024;194(12). doi:10.1002/ajmg.a.63819

BibTeX
@article{Klamut2024,
  author = {Klamut, Natalia and Bothwell, Samantha and Carl, Alexandra E and Bamba, Vaneeta and Law, Jennifer R and Brickman, Wendy J and Klein, Karen O and Kanakatti Shankar, Roopa and Pinnaro, Catherina T and Fechner, Patricia Y and Prakash, Siddharth K and Gutmark-Little, Iris and Howell, Susan and Tartaglia, Nicole and Good, Marybel and Ranallo, Kelly C and Davis, Shanlee M},
  title = {Prevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X/47, XXX ): Results from the InsighTS Registry},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  volume = {194},
  number = {12},
  doi = {10.1002/ajmg.a.63819}
}
Kostenlos starten →